NCT05433610

Brief Summary

Patients with heart failure (HF) have a reduced exercise tolerance as the main result of the disease. This exercise intolerance is due to heart conditions, but also to dysfunction of the respiratory and peripheral muscles. Various factors such as chronic hypoxia, oxidative stress, nutritional depletion, peripheral muscle disuse, effects of medications, and sympathetic-vagal imbalance are major contributors to deconditioning. In this scenario, the use of non-invasive ventilatory support (NIV) arises as an adjunct to cardiac rehabilitation in the attempt to improve the functional capacity of patients, since NIV reduces work of breathing, improves oxygenation and increases lung compliance associated with improved ejection volume, due to increased intrathoracic pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable heart-failure

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 27, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

June 28, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2022

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

5 months

First QC Date

June 15, 2022

Last Update Submit

December 14, 2022

Conditions

Keywords

RehabilitationExercise TestHeart FailureAerobic Exercise

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in exercise tolerance

    Change in Maximun Walking time tolerated in a Constant Treadmill Load Test (CTLT) in seconds on treadmill between PS, CPAP and WNIT

    At the end of exercise

Secondary Outcomes (8)

  • Change in Dyspnea

    At the end of exercise

  • Change in Cardiac Rate

    At the end of exercise

  • Change in Oxygen Saturation

    At the end of exercise

  • Change in Global Comfort

    At the end of exercise

  • Change in Lower Limbs Fatigue

    At the end of exercise

  • +3 more secondary outcomes

Study Arms (3)

Constant Treadmill Load Test (CTLT) using non-invasive ventilation (NIV)

EXPERIMENTAL

Exercise capacity testing using PS in HF patients

Device: Non-invasive Ventilation

Constant Treadmill Load Test (CTLT) using NIV

EXPERIMENTAL

Exercise capacity testing using CPAP in HF patients

Device: Non-invasive Ventilation

Constant Treadmill Load Test (CTLT) without NIV

ACTIVE COMPARATOR

Exercise capacity testing without NIV in HF patients

Device: Non-invasive Ventilation

Interventions

Exercise capacity testing using the device

Also known as: Noninvasive Ventilations
Constant Treadmill Load Test (CTLT) using NIVConstant Treadmill Load Test (CTLT) using non-invasive ventilation (NIV)Constant Treadmill Load Test (CTLT) without NIV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ejection fraction demonstrated by echocardiography ≤ 40% (in the last 12 months).
  • NYHA functional class I - III.
  • Clinical stability, defined as four weeks prior to the start of the study without hospitalizations.
  • Signed informed consent.
  • ≥ 18 years of age.

You may not qualify if:

  • Chronic obstructive pulmonary disease (COPD), unstable angina or significant arrhythmias.
  • Myocardial infarction in the last 3 months, primary valve disease and anemia (hemoglobin under 13 g/dl for men or 12 g/dl for women).
  • Patients who are smokers or ex-smokers of less than one year.
  • Patients with cognitive impairment that prevents the correct understanding of the evaluations.
  • Any neuromuscular or osteoarticular condition that limits test performance.
  • Refusal to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Gran Rosario

Rosario, Santa Fe Province, 2000, Argentina

Location

Related Publications (5)

  • O'Donnell DE, D'Arsigny C, Raj S, Abdollah H, Webb KA. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med. 1999 Dec;160(6):1804-11. doi: 10.1164/ajrccm.160.6.9808134.

    PMID: 10588589BACKGROUND
  • Bittencourt HS, Reis HF, Lima MS, Gomes M Neto. Non-Invasive Ventilation in Patients with Heart Failure: A Systematic Review and Meta-Analysis. Arq Bras Cardiol. 2017 Feb;108(2):161-168. doi: 10.5935/abc.20170001. Epub 2017 Jan 16.

    PMID: 28099587BACKGROUND
  • Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000 May;71(5):1033-47. doi: 10.1093/ajcn/71.5.1033.

    PMID: 10799364BACKGROUND
  • Borghi-Silva A, Carrascosa C, Oliveira CC, Barroco AC, Berton DC, Vilaca D, Lira-Filho EB, Ribeiro D, Nery LE, Neder JA. Effects of respiratory muscle unloading on leg muscle oxygenation and blood volume during high-intensity exercise in chronic heart failure. Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2465-72. doi: 10.1152/ajpheart.91520.2007. Epub 2008 Mar 28.

    PMID: 18375714BACKGROUND
  • Mazzucco G, Torres-Castro R, Intelangelo L, Lista-Paz A, Escalante JP, Zumeta-Olaskoaga L, Veiga G, Etxarri AA. Is non-invasive ventilation effective in improving the exercise capacity in patients with cardiac heart failure?: A randomised crossover trial. PLoS One. 2025 Jul 7;20(7):e0327399. doi: 10.1371/journal.pone.0327399. eCollection 2025.

MeSH Terms

Conditions

Heart Failure

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Interventional, crossover, randomized.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 15, 2022

First Posted

June 27, 2022

Study Start

June 28, 2022

Primary Completion

December 5, 2022

Study Completion

December 5, 2022

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

Locations